openPR Logo
Press release

Naloxone Market trend, outlook 2025

06-26-2018 05:30 PM CET | Health & Medicine

Press release from: Coherent Market Insights - Pharmaceutical Industry

Naloxone is an opioid antagonist used to counter the effects of opioid overdose, such as morphine and heroine. Naloxone is indicated for use in opioid overdose to counteract life-threatening depression of the central nervous system and respiratory system, allowing an overdose victim to breathe normally. Naloxone is non-scheduled prescription medication, which in most cases, is administrated by emergency response personnel or minimally trained personnel, and is thus ideal for treating overdose in people who are prescribed opioid pain medication. Naloxone can be administrated through parenteral route, by injecting in the muscle or vein.

Request for Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1804
Naloxone Market Drivers
Opioids such as morphine, heroin, tramadol, oxycodone, and methadone have tendency to cause substance dependence, which is further characterized by a strong desire to take opioids, impaired control over opioid use, persistent opioid use despite harmful consequences, increased tolerance, and a physical withdrawal reaction when opioids are discontinued. Moreover, people dependent on opioids are most likely to suffer from drug overdose. Increasing number of opioid dependent patients, resulting in opioid overdose is expected to significantly increase demand for opioid antagonist medication, thereby increasing growth of naloxone market. According to the World Health Organization (WHO), November 2014 data sheet, around 69,000 people are estimated to die from opioid overdose each year, with 15 million people estimated to be suffering from opioid dependence (addiction to opioids). Among the total number of opioid dependence people, majority of are dependent on illicitly cultivated heroin, while an increasing proportion of people use prescription opioids. According to the United States Department of Health and Human Services (HHS), January 2018 updated data findings, in 2016, 42,249 people died from overdosing on opioids. Additionally, 2.1 million people misused prescription opioids for the first time.
Increasing engagement of government and private organizations in spreading awareness regarding availability of naloxone medications in the pharmacies and government approved co-payment programs to back the naloxone coverage throughout countries, worldwide, is expected to significantly increase growth of the naloxone market in the near future. The New York State Department of Health AIDS Institute offers benefits to people living in New York, through the Naloxone Co-payment Assistance Program (N-CAP). According to the N-CAP, individual with prescription coverage under the health insurance plan, can avail benefits upto US$ 40 for each prescription dispensed for co-payments of naloxone. Furthermore, according to the New York State- Department of Health, April 2018, revised data findings, individuals who are themselves or their family members or friends at risk for an overdose may acquire naloxone thorough over 2000 pharmacies in the New York State, without bringing in a prescription. World Health Organization (WHO), recommends naloxone as take-home antidote medication for people who likely to witness an opioid overdose.
Naloxone Market Restraints
Increasing gap between opioid overdose medication and its implementation is high. According to the WHO: November 2014, only 42% of countries provide access to effective treatment options for opioid dependence while less than 10% of people worldwide in need of opioid treatment have access to treatment. Limited accessibility to naloxone, in turn, poses as a major factor restraining growth of the naloxone market.

Request for TOC :  https://www.coherentmarketinsights.com/ongoing-insight/toc/1804
Naloxone Market – Regional Analysis
Geographically, the global naloxone market is segmented into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa. The North America naloxone market holds a major share in the global naloxone market, owing to increasing prevalence of opioid overdose, combined with growing number of healthcare regulatory organizations involved in offering opioid overdose treatment management options in the region.
For instance, in March 2016, Health Canada removed the prescription status for naloxone when used outside a hospital setting. After which, the College of Pharmacists of British Columbia, included naloxone in a Schedule II drug, making it available behind the counter of pharmacies in British Columbia. Furthermore, according to guidelines published in the Canadian Medical Association Journal, in March 2018, Canadian Medical Association recommends buprenorphine-naloxone as the preferred first-line treatment in opioid addiction. According to Canadian Medical Association Journal: March 2018, in 2016, in Canada, the rate of opioid-related deaths was 7.9 per 100,000 (a total of 2861 deaths), with the number of rapidly increasing. According to the data published by United Nations International narcotics Control Board: 2017, people in the U.S. consume more opioids than those in any other country, making the U.S. a lucrative market for growth of naloxone.
Naloxone Market – Competitor
Some of the key players operating in the global naloxone market are ADAPT Pharma, Inc., INSYS Therapeutics, Inc., Pfizer Inc., Amphastar Pharmaceuticals Inc., Mylan N.V., Opiant Technologies Inc., Kaleo, Inc., Alkermes, BioCorRx Inc., and Novartis International AG (Sandoz).
Naloxone Market Taxonomy
By Type
Branded
Generic
By Administration
Intranasal Administration
Intramuscular Administration
Intravenous Administration
By Distribution Channels:
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
Latin America
Europe
Asia Pacific
Middle East
Africa

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Naloxone Market trend, outlook 2025 here

News-ID: 1098906 • Views:

More Releases from Coherent Market Insights - Pharmaceutical Industry

Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 2026 : Key Players are Roche AG, Thermo Fisher Scientific Inc., Merck & Co., Inc., Pfizer, Inc., Actelion Pharmaceuticals
Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 20 …
Coherent Market Insights released a new market study on 2018-2026 Radiopharmaceuticals Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Ask For Sample Copy of Research
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2026
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2 …
Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development. Ask For a Sample Copy of This Business Report @
Cannabis Testing Services Market: New Business Opportunities and Investment Research Report 2018-2026
Cannabis Testing Services Market: New Business Opportunities and Investment Rese …
Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purpose. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal benefits. Moreover, commercialization of cannabis-based products under the legalized standards require successful cannabis testing, which further results in lucrative growth opportunity for market players. Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2976 Market
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insignificant CAGR Till 2025 With Top Players Novartis AG, Celgene Corp, Otsuka Pharmaceutical Co., Sandoz, Dr Reddys Laboratories, Pharmascience
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insigni …
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around

All 5 Releases


More Releases for Naloxone

Naloxone Market To Cut Through Linear Growth
The Naloxone Market is expected to grow at an unstoppable rate In Upcoming Years. With environmental health being a matter of concern, everything - right from public transport networks, power supply, and storage of waste to monitoring the ecological balance is being taken up by IoT and AI. It could, thus, be inferred that with "smart cities" would come "smart end-user solutions" in the years to come. Naloxone is an opioid
Naloxone Market Insights, Overview, Analysis and Forecast 2021-2027
The global “Naloxone Market” research report explains strategic and profitable insights into key growth factors, the competitive landscape, and the growing popularity of Naloxone market trends. In this professional report, revenue analysis, market size, and developing technologies of top main rivals are among the factors impacting growth. The Naloxone Market research gives a large analysis of regional market dynamics, segmentation, business strategy, product portfolio, and recent industry developments. The Naloxone Market
Naloxone Market Industry Analysis, Growth, Trends and Forecast - 2027
Naloxone market size is projected to reach US$ 32890 million by 2027, from US$ 27630 million in 2019, at a CAGR of 2% during 2021-2027. Naloxone is an opioid antagonist used to treat opioid overdose. Opioids are pain relievers used to treat chronic pain, but the non-medical use of opioids is rapidly increasing. Because opioids both relieve pain and cause euphoria, opioid abuse is on the rise worldwide. According to the
Naloxone Market Size, Growth, Segmentation, Share, Forecast 2019-2025
The global Naloxone market size is expected to grow at a CAGR of 2% during 2019-2025. Naloxone is an opioid antagonist used to treat opioid overdose. Opioids are pain relievers used to treat chronic pain, but the non-medical use of opioids is rapidly increasing. Because opioids both relieve pain and cause euphoria, opioid abuse is on the rise worldwide. According to the National Institute of Drug Abuse, about 130 people
Naloxone Spray Market Size, Share, Development by 2024
LP INFORMATION offers a latest published report on Naloxone Spray Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Naloxone Spray market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular,
Naloxone Sales Market 2017 by Current & Upcoming Trends
Qyresearchreports include new market research report Global Naloxone Sales Market Report 2017 to its huge collection of research reports. This business and commerce study on the global Naloxone market has been freshly compiled by a group of professional market research analysts and aspires to serve a reliable business tool for the stockholders of this market. The report begins with an overview of the global Naloxone market, evaluating market performance in terms